Cleanspace Holdings Ltd
ASX:CSX
Relative Value
The Relative Value of one
CSX
stock under the Base Case scenario is
0.37
AUD.
Compared to the current market price of 0.5 AUD,
Cleanspace Holdings Ltd
is
Overvalued by 26%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
CSX Competitors Multiples
Cleanspace Holdings Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
|
Cleanspace Holdings Ltd
ASX:CSX
|
39.1m AUD | 2 | -81.8 | -25.7 | -25.7 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
197B USD | 4.4 | 30.2 | 17.3 | 23.8 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
178.9B USD | 17.7 | 62.4 | 47.4 | 58.2 | |
| US |
|
Stryker Corp
NYSE:SYK
|
147B USD | 5.8 | 45.2 | 22.9 | 27.7 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
122.8B USD | 3.5 | 26.7 | 14.5 | 21.2 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
108.3B USD | 5.4 | 37.3 | 21.8 | 29.3 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
46.8B EUR | 2 | 22.2 | 12.2 | 17.2 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
51.1B USD | 12 | 48.8 | 34.6 | 38.3 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
49B USD | 2.2 | 27.7 | 10.7 | 18.1 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
49.7B USD | 8.2 | 46.3 | 25.5 | 28 | |
| US |
|
Resmed Inc
NYSE:RMD
|
37.5B USD | 7 | 25.3 | 17.9 | 19.9 |